|
|
Stada Arzneimittel AG - Comparative Business Analysis Snapshot
Business Description
Stada Arzneimittel AG(STADA). The Group's principal activity is to manufacture generic drugs. The Group operates through two core segments: Generics and Branded products. Through Generics segment, the Group offers medicines after the expiration of their patents at the same quality but for significantly lower prices. Through Branded Products segment, the Group focuses on multisource products with off-patent active ingredients. The Group's current branded products portfolio includes primarily non-prescription which are called over-the-counter products (OTC products), and in some national markets also prescription drugs. The non-core segment includes commercial business. The Group mainly operates in Europe, America and Asia.
Competitor Analysis
This analysis compares Stada Arzneimittel AG with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
